Dividends & Buybacks ·
NexGel executes 1-for-20 reverse stock split effective Oct 12
NXGLNexgel, Inc.
NexGel, Inc. filed a Certificate of Amendment to its Certificate of Incorporation with the State of Delaware on October 7, 2026, to effect a one-for-twenty reverse stock split of its common stock. The transaction becomes effective at 12:01 a.m. Eastern Time on October 12, 2026. Under the terms, every twenty shares held prior to the effective time are combined into one share. Fractional shares resulting from the split will be rounded up to the nearest whole share rather than paid out in cash. The company's common stock will continue trading on the Nasdaq Capital Market under the symbol NXGL with a new CUSIP number, while the par value remains $0.001 per share. NexGel develops and manufactures medical devices for wound care and tissue regeneration.